Ophthalmic AI tools show 35-40% accuracy gains in diabetic retinopathy screening, driving market growth to $2.1B. Recent FDA clearances and…
diabetic retinopathy
1 post
Ophthalmic AI tools show 35-40% accuracy gains in diabetic retinopathy screening, driving market growth to $2.1B. Recent FDA clearances and…